University of Massachusetts Medical School Faculty Publications
Title
Clinical trials of biosimilars should become more similar
UMMS Affiliation
Division of Rheumatology, Department of Medicine
Publication Date
1-1-2017
Document Type
Editorial
Disciplines
Rheumatology
Abstract
As many more biosimilars are in development, we recommend that clinical trial design be standardised. This standardisation could be agreed upon and overseen by regulatory agencies around the world. The introduction of consistency across clinical trials should increase confidence in these more affordable biopharmaceuticals, both within the healthcare community and among patients.
Keywords
Anti-TNF, Disease Activity, Inflammation, Rheumatoid Arthritis, Treatment
DOI of Published Version
10.1136/annrheumdis-2015-208113
Source
Ann Rheum Dis. 2017 Jan;76(1):4-6. doi: 10.1136/annrheumdis-2015-208113. Epub 2016 Aug 25. Link to article on publisher's site
Related Resources
Journal/Book/Conference Title
Annals of the rheumatic diseases
PubMed ID
27566795
Repository Citation
Kay, Jonathan and Isaacs, John D., "Clinical trials of biosimilars should become more similar" (2017). University of Massachusetts Medical School Faculty Publications. 1215.
https://escholarship.umassmed.edu/faculty_pubs/1215